The CXCL12/CXCR4 axis represents a promising prognostic marker and a potential target for therapy in oncology, as it has been shown to be operative in about 20 different cancer types where it promotes cancer cell survival and proliferation, tumor angiogenesis, and cancer cells migration to metastatic sites. This evidence concerns the gene CXCL12 and neoplasm.